Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?

Published:2021-07-06 Issue:4 Volume:22 Page:1171-1188
ISSN:1389-9155
Container-title:Reviews in Endocrine and Metabolic Disorders
language:en
Short-container-title:Rev Endocr Metab Disord

Author:

Bakbak Ehab,Terenzi Daniella C.,Trac Justin Z.,Teoh Hwee,Quan Adrian,Glazer Stephen A.,Rotstein Ori D.,Al-Omran Mohammed,Verma Subodh,Hess David A.

Funder

Institute of Nutrition, Metabolism and Diabetes

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s11154-021-09669-7.pdf

Reference153 articles.

1. Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–88. https://doi.org/10.1016/S0140-6736(18)32203-7.

2. Bramante CT, Lee CJ, Gudzune KA. Treatment of Obesity in Patients With Diabetes. Diabetes Spectr. 2017;30:237–43. https://doi.org/10.2337/ds17-0030.

3. Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J. 2013;34:2444–52. https://doi.org/10.1093/eurheartj/eht142.

4. International Diabetes Federation. IDF Diabetes Atlas. (2019) 9th Edn.

5. Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81. https://doi.org/10.1016/j.diabres.2018.02.023.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes;American Journal of Physiology-Heart and Circulatory Physiology;2024-08-01

2. Comparative analysis of newer classes of antidiabetics and the concept of pharmaceutical care – dealing with therapeutic problems;Pharmacia;2024-02-22

3. GLP1R (glucagon-like-peptide-1 incretin receptor), diabetes and obesity phenotypes: An in silico approach revealed new pathogenic variants;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-02

4. Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity;Cardiovascular Research;2023-12

5. Evidence of Bariatric Surgery Benefits Cardiac Function in Non-HFpEF Patients with Obesity: a Meta-Analysis;Obesity Surgery;2023-09-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3